key: cord-0018536-3fuxb56d
authors: TANIHARA, Fuminori; HIRATA, Maki; OTOI, Takeshige
title: Current status of the application of gene editing in pigs
date: 2021-04-10
journal: J Reprod Dev
DOI: 10.1262/jrd.2021-025
sha: c9a97513ccc954927d9d46f2cea4253ccb0d8108
doc_id: 18536
cord_uid: 3fuxb56d

Genetically modified animals, especially rodents, are widely used in biomedical research. However, non-rodent models are required for efficient translational medicine and preclinical studies. Owing to the similarity in the physiological traits of pigs and humans, genetically modified pigs may be a valuable resource for biomedical research. Somatic cell nuclear transfer (SCNT) using genetically modified somatic cells has been the primary method for the generation of genetically modified pigs. However, site-specific gene modification in porcine cells is inefficient and requires laborious and time-consuming processes. Recent improvements in gene-editing systems, such as zinc finger nucleases, transcription activator-like effector nucleases, and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (CRISPR/Cas) system, represent major advances. The efficient introduction of site-specific modifications into cells via gene editors dramatically reduces the effort and time required to generate genetically modified pigs. Furthermore, gene editors enable direct gene modification during embryogenesis, bypassing the SCNT procedure. The application of gene editors has progressively expanded, and a range of strategies is now available for porcine gene engineering. This review provides an overview of approaches for the generation of genetically modified pigs using gene editors, and highlights the current trends, as well as the limitations, of gene editing in pigs.

Genetically modified animals, especially rodents, are widely used as biomodels to elucidate animal physiology and disease mechanisms, including human traits and diseases. However, for efficient translational and preclinical studies, additional insights from non-rodent animal models are important [1] . Pigs are similar to humans in several respects, particularly in anatomy and physiology. Additionally, they breed year-round with large litter sizes. As pigs are considered an excellent animal model, gene modification is expected to improve the value of pig resources for biomedical research. The first transgenic pig, reported in 1985 [2] , was produced by microinjection of exogenous DNA into the pronuclei of porcine zygotes through a fine glass needle. Subsequently, pronuclear injection has been used to establish genetically modified pig lines [3, 4] . This technique is simple but requires technical proficiency. Furthermore, the low efficiency of generating founder pigs carrying mutations and the random integration of injected DNA into the genome without control of the copy number result in unstable phenotypes, gene silencing, and unpredictable gene expression, thereby limiting the application of such mutant pigs.

In mice, the establishment of embryonic stem cells (ESCs) promoted the development of genetically modified animals owing to the production of chimeras with germline transmission, which represents a significant advance in biomedical research. However, for pigs, stem cell lines, including ESCs, which contribute to the germline, are not available [5] . Since somatic cell nuclear transfer (SCNT) has been established in pigs [6] [7] [8] , SCNT using genetically modified somatic cells as nuclear donors has been widely chosen as a method for the generation of genetically modified pigs. The correct use of somatic cells carrying the desired mutation, including multiple gene modifications, as nuclear donors virtually ensures that pigs will carry the desired mutations and the appropriate number of copies of the transgene. Furthermore, direct gene editing during embryogenesis often induces genetic mosaicism, which complicates the phenotypic analysis of founders, whereas SCNT can ensure non-mosaic genotypes in the resulting pigs. These characteristics, which have significant advantages, show that SCNT can be used as a primary method for the generation of genetically modified pigs.

SCNT overcomes the low efficiency and random transmission of gene modifications in delivered piglets that characterize pronuclear microinjection. However, site-specific gene insertion in porcine cells is limited by the low efficiency of homologous recombination (HR) and the sophisticated selection processes within cells following gene modification procedures, necessitating laborious and time-consuming processes [9] . Recently developed precise nuclease-mediated gene editing systems have dramatically improved gene modification in pigs. This review describes the production of genetically modified pigs using gene editors, provides an overview of approaches for the generation of genetically modified pigs using various types of gene editors, and highlights current trends, including the establishment of disease models and research on pig-to-human transplantation, as well as the limitations of gene editing in pigs.

Engineered endonucleases, including artificial nucleases, such as zinc finger nucleases (ZFNs) [10, 11] and transcription activatorlike effector nucleases (TALENs) [12] , as well as RNA-guided endonucleases, such as the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (CRISPR/ Cas) system [13, 14] , are major innovations for gene modification in somatic cells, stem cells, and zygotes/embryos of various animal species. These nucleases have precise DNA-binding ability and generate double-strand breaks (DSBs) at the desired genomic locus. DSBs trigger endogenous DNA repair via non-homologous end-joining (NHEJ) or homology-directed repair (HDR) pathways [15] . NHEJ occurs when the ends of a DSB are rejoined without any DNA template to guide this repair. Successfully repaired targeted sequences are repeatedly cut by gene editors, resulting in the frequent introduction of short DNA insertions/deletions (indels). These indels create targeted gene knockouts by inducing a frameshift in the codons, which is followed by the formation of a premature termination codon [12] . HDR relies on donor DNA with homologous arms from sister chromatids, homologous chromosomes, exogenous DNA templates, or single-strand donor oligonucleotides (ssODNs), and enables gene knock-in and the introduction of the desired point mutation. In general, the frequency of HDR is lower than that of NHEJ in most cell types [16] .

ZFNs are gene editors composed of DNA-binding domains (zinc finger proteins) and a DNA-cutting domain (the chimeric restriction nuclease FokI) acting as a heterodimer. Zinc finger domains recognize specific sequences in genomic DNA, after which FokI nuclease and the zinc finger protein induce DSBs at the targeted position. However, the practical use of ZFNs in laboratories is hindered by high costs and technical difficulties [17] . TALENs are conceptually similar to ZFNs. Transcription activator-like effectors (TALEs) are naturally occurring proteins found in the plant pathogenic bacterial genus Xanthomonas. TALENs have a TALE as the DNA-binding domain and FokI as the cleavage domain. The preparation of TALENs is simpler than that of ZFNs; therefore, they are preferred in laboratory settings for gene editing.

ZFNs and TALENs are artificial nucleases. In contrast, CRISPR/ Cas9 is an RNA-guided endonuclease that is derived from an adaptive bacterial immune system component [13, 14, 18] . The CRISPR/Cas9 system comprises a guide RNA (gRNA) and Cas9 nuclease. Since the first practical demonstration of gene editing using the CRISPR/Cas9 system in 2013, the system has been dramatically improved. Various gRNA/Cas9-related expression plasmids, Cas9 proteins, tools for gRNA design, and subsequent gRNA order/purchase systems are now available [19] . The system does not require specialized methodology or equipment; this has contributed to its recent widespread use.

Off-target effects, which are unexpected DNA cleavages caused by the binding of gene editors to unintended genomic sites, are of major concern in gene editing, especially using the CRISPR/Cas9 system; these have limited the research and clinical applications of gene editors [20, 21] . Carey et al. highlighted the frequency of off-target events induced by cytoplasmic microinjection of CRISPR/Cas9 during embryogenesis [22] ; they detected off-target cleavage, but concluded that the frequency was low. Zhou et al. also detected off-target events induced by cytoplasmic microinjection of CRISPR/Cas9 [23] . Other off-target events were observed during SCNT-mediated production of gene-edited pigs using a ZFN [24] and CRISPR/Cas9 [25, 26] , but mutations were only observed in non-coding regions in two out of the three studies [24, 26] . To the best of our knowledge, off-target events in gene-edited offspring have not been detected in any other study. Choi et al. showed that there was no off-target cleavage in offspring when using whole-genome sequencing [27] . To date, off-target events have not produced any critical problems in geneedited porcine offspring. Various approaches have been developed to minimize these off-target effects, such as off-target detection by algorithmically designed software and genome-wide assays, the use of cytosine or adenine base editors, prime editing, and the chemical modification of gRNA [19, 28] . Furthermore, Cas9 variants such as Cas9 nickase [29] , which cleaves only the target strand (by double nicking), and catalytically dead Cas9 combined with FokI nuclease (FokI-dCas9) [30, 31] , reduce off-target events. Variants suggested by structural studies of Cas9, such as Cas9-HF1 [32] , evo-Cas9 [33] , eSpCas9 [34] , and Hypa-Cas9 [35], also improve gene editing efficiency and discrimination against off-target events. The careful design of binding modules or gRNAs and improved application methods will minimize off-target effects in founder generations and reduce the labor required to analyze off-target candidates.

The ZFN, TALEN, and CRISPR/Cas9 systems enable efficient gene targeting and the introduction of multiallelic modifications into somatic cells, simplifying the preparation of donor cells for SCNT in pigs. Furthermore, gene editors have enabled the direct modification of genomic DNA in zygotes/embryos using cytoplasmic microinjection and electroporation (Fig. 1) .

Gene editors enable the one-step knockout of genes in somatic cells without any marker or exogenous DNA fragments. Such gene-edited cells have accelerated SCNT-mediated production of genetically modified pigs. Gene editors also facilitate multiple gene editing and knock-in of exogenous genes; hence, double-[36-38], triple-[39-41], and quadruple-gene-edited pigs [42] and knock-in pigs [43, 44] have been generated using the SCNT technique. Following appropriate selection of donor cells after gene editing, the delivered piglets carry the desired genotypes. Furthermore, SCNT does not result in mosaicism, which is observed in gene-editor-mediated direct gene modification during embryogenesis, and thus aids in the phenotypic analysis of founder pigs. SCNT is the primary method for generating gene-edited pigs. However, offspring derived from reconstructed embryos often show abnormalities, such as birth defects, abortions, and early postnatal death; this is a limitation of SCNT [45] .

Microinjection of gene editors into zygotes/embryos: The direct introduction of gene editors into the cytoplasm, an alternative to SCNT, simplifies the genetic modification of fertilized zygotes/embryos. Porcine oocytes have high lipid contents; therefore, centrifugation is required to visualize the pronuclei for successful pronuclear injection at the zygote stage. However, gene editors are generally supplied with nuclear localization signals, making the centrifugation procedure and maneuvering of the glass needle toward the pronuclei unnecessary. Cytoplasmic microinjection-mediated gene-edited pigs have been produced using gene editors in the early stages of their development [46] [47] [48] . Microinjection also enables the introduction of large molecules; therefore, microinjection-mediated knock-in pigs can be established [49] . An advantage of microinjection-mediated gene editing is the high viability of the manipulated zygotes/embryos. After the transfer of microinjected zygotes/embryos, the litters obtained from manipulated embryos tend to be larger than those from embryos generated by SCNT [50] . Although the results of embryo transfer depend on the condition of the recipient surrogates and operator skill in embryonic manipulation, the high viability of the zygotes/embryos and resulting piglets reduces labor.

Delivery of CRISPR/Cas9 system via electroporation during embryogenesis: Electroporation-mediated gene editing is a micromanipulation-free method in which large numbers of gene-edited zygotes/embryos can be prepared by introducing gene editors into zygotes. In mice, electroporation is widely used to introduce gene editors [51] . Gene editing via electroporation has also been applied to porcine zygotes [52] , with successful gene modification (knockout) [52] [53] [54] [55] . Electroporation-mediated gene editing requires no specialized equipment and benefits from a simple process and high zygote viability. However, the introduction of large molecules, including transgenes for knock-in, by electroporation alone is difficult in pigs. Generally, the molecular uptake into cells via electroporation is proportional to the field strength, pulse length, and number of pulses used. Porcine in vitro-fertilized zygotes/embryos are sensitive to electricity, and high voltages are harmful, unlike in mice [52, 56] . Hence, a knock-in system for large transgenes via electroporation has not been established. Further research focusing on electroporationmediated gene editing and the proper choice of electroporation and cytoplasmic microinjection techniques (depending on the study purpose and type of mutation) is needed.

Gene editors have been used to generate genetically modified pigs. In 2011, fifteen years after the initial report of the concept of ZFNs [10] , genetically edited pigs were generated using them [24, 57, 58] . TALEN and the CRISPR/Cas9 system were also applied to generate genetically modified pigs soon after practical gene editing in mammalian cells was demonstrated. The low-density lipoprotein receptor (LDLR)-knockout pigs reported in 2012 were the first to be generated using a TALEN [59] . Using the CRISPR/Cas9 system, Whitworth et al. generated CD163-and CD1D-modified pigs using SCNT and cytoplasmic microinjection to confer disease resistance against porcine reproductive and respiratory syndrome [47] . Recently, gene editors have been utilized extensively for the rapid establishment of valuable engineered pig lines that can be used in human medicine, e.g., as disease models and organ donors.

Pigs are among the best animals for disease models in medical research, which has implications for translational and preclinical research, as they are intermediate between mice and humans in terms of their physiological and anatomical relationships. Selection of the appropriate pig breed or strain, and age is important for the application of surgical and non-surgical procedures typically used in human medicine (e.g., catheterization, heart surgery, and endoscopy). These clinical procedures are particularly difficult or impossible to perform in many other animal models, including rodents, owing to the small size of the species. Various types of gene-edited pigs have been generated to establish models for intractable diseases (Table 1) . Gene editing is expected to accelerate the application of pig lines as disease models.

Pigs are ideal tissue/organ donors for humans owing to the high similarity of their organs, especially in terms of size and structure. Pig-to-human xenotransplantation is a solution to the shortage of organs for human transplantation. However, xenoantigens cause hyperacute rejection and limit the success of interspecific xenografts. Therefore, genes involved in xenoantigen biosynthesis, such as GGTA1, CMAH, and B4GALNT2, are key targets for improving the [72] . Gene editors enable various approaches to regulating immune rejection. Additional major hurdles for successful xenotransplantation are organ size and the elimination of porcine endogenous retrovirus (PERV). Xeno-organs donated by genetically modified pigs car-rying the genetic background of domestic pigs can grow rapidly; this can generate incompatibility with recipients and impair their long-term function after transplantation. Growth hormone receptor (GHR)-deficient pigs with reduced organ size [73, 74] and subsequent GHR/GGTA1 double-knockout pigs expressing the human cluster of differentiation (hCD46) and human thrombomodulin (hTHBD) [75] have been generated by gene editing. This approach will improve the implementation of xenotransplantation. Furthermore, the risk of PERV transmission to humans after xenotransplantation is a concern [76, 77] . PERVs constitute an integral part of the porcine genome and can be expressed as infectious virus particles. Infection by PERVs in human cells has been observed using in vitro co-culture assays, which demonstrated the possibility of a new epidemic infectious disease induced by xenotransplantation. PERVs are present in various proportions in the whole porcine genome, depending on the pig breed and tissue type, making the inactivation of PERVs a difficult task; however, genome-wide gene editing has the potential to eliminate PERVs from porcine tissues. Gene editing targeting PERVs has been demonstrated using CRISPR/Cas9 [78, 79] , and PERV-inactivated pigs have also been generated using SCNT [80]. These hurdles have thus been partially overcome using various gene editing techniques in pigs, improving the feasibility of pig-to-human xenotransplantation. An alternative strategy for producing functional and transplantable tissues or organs is to build interspecies chimeras at the embryonic level by blastocyst complementation, which involves the injection of human ESCs or human induced pluripotent stem cells into genetically modified porcine embryos lacking the ability to generate specific organs. Missing organs (empty niches) are expected to develop from these injected stem cells, resulting in the generation of organs derived from human cells. 

Gene-edited Pigs Figure 2 summarizes recent trends in the number of articles reporting the generation of genetically modified pigs using gene editors available via PubMed. The search terms used were "pig," "ZFN," "TALEN," and "CRISPR"; these picked up studies demonstrating the production of gene-edited pigs/fetuses. The gene editors (ZFN, TALEN, and/or CRISPR-related systems) and methods for generating gene-edited pigs (SCNT, cytoplasmic microinjection, and/or electroporation) used in the studies were investigated. Although the introduction of gene editors during embryogenesis using microinjection or electroporation has an advantage over SCNT with respect to the simplicity of the procedure, the use of SCNT is more common. In this section, we discuss the limitations and future prospects of direct gene editing during embryogenesis.

Genetic mosaicism, in which a single individual carries multiple genotypes, contributes to the inability to generate mutant pigs via direct gene editing during embryogenesis [85] . In founder animals, both the direct injection and electroporation-mediated introduction of gene editors into the cytoplasm often induce mosaicism due to the delayed expression of mRNA-related gene editors or remnant activity of the gene editors throughout the cell division process [85] [86] [87] [88] [89] . Mosaicism complicates the phenotypic analyses of founders, which require the F1 generation. Owing to the long gestation period and time to reach sexual maturity in pigs, production of the F1 generation involves a tremendous amount of time and cost, seriously limiting research progress. Mosaicism is detected by genotyping (e.g., by the detection of multiple alleles, typically three alleles or more, or extreme deviations in allele frequencies). We investigated previous examples of gene modification during embryogenesis by cytoplasmic microinjection or electroporation using gene editors, including TALENs and ZFNs, and found that mosaicism in gene-edited offspring was reported in 18 out of 23 studies (Table 2) . Mosaicism occurs at various frequencies [85] , and the type of gene editor and modification [90, 91] , introduction method, animal species, and introduced component of gene editors (e.g., expression plasmid, mRNA, and protein/nuclease) seem to be potential factors. Appropriate timing of the introduction of gene editors during embryogenesis is considered a key factor in reducing mosaicism [87] . Microinjection of the CRISPR/Cas9 system into the cytoplasm of germinal vesicle-stage oocytes successfully generated non-mosaic genome-edited porcine embryos [92] . Onuma et al. demonstrated that microinjection of the CRISPR/Cas9 system during meiotic maturation preferentially induces heterozygous mutations without mosaicism after germinal vesicle breakdown and chromosome condensation [93] . Conversely, electroporation-mediated gene editing in mature oocytes has demonstrated that the type of egg may influence development after electroporation treatment and the mutation rate in the resulting blastocyst; however, mosaicism is not controlled [94] . A simple approach, the optimization of CRISPR/Cas9 component concentrations, is effective in increasing gene editing efficiency in cytoplasmic microinjection [95] and electroporation [96] . Such strategies will improve gene editing efficiency during embryogenesis. Further optimization of the methods for the application of gene editors in pigs is required.

Currently, the generation of multiple-gene-edited pigs is an important research goal aimed at a better understanding of complex biological processes and the management of redundancies and compensatory changes in signaling pathways. Gene editors can induce mutations in multiple targeting sites, enabling the one-step generation of double-and triple-knockout pigs via direct introduction into zygotes/embryos. Multiple-gene-edited animals have been generated by cytoplasmic microinjection of CRISPR/Cas9 in mice [97, 98] , rats [99] , and monkeys [100] . In pigs, the SCNT technique is the primary method, as described above, and there are few reports of one-step generation of multiple-gene-edited pigs by microinjection or electroporation [101] . As the number of simultaneously targeted genes increases, the risk of insufficient gene knockout, including mosaicism, will also increase. The investigation of in vitro electroporation-mediated multiple-gene editing has progressed [102, 103] . The reductions in mosaicism and the optimization of multiple-gene editing efficiency in zygotes/embryos achieved to date are inadequate; highly efficient direct gene modification is expected to be achieved in the near future.

Knock-in of transgene(s) is a crucial approach for the generation of valuable pigs for experimental research, such as those with knock-in of human complement regulatory proteins (CD46, CD55, CD59, etc.) to reduce complement activity in xenotransplantation [41] . Although most knock-in pigs have been generated by SCNT using gene-edited somatic cells carrying transgenes as donor cells [31, 43, 44, [104] [105] [106] [107] [108] [109] , cytoplasmic microinjection of gene editors can also be used to successfully generate knock-in pigs [49, 110] . However, knock-in pigs have not been successfully generated by electroporation-mediated methods, because the introduction of large transgenes for knock-in is difficult using electroporation alone in pigs, as described above. Direct knock-in during embryogenesis using gene editors has a wide range of applications. Although HDR followed by DSBs induced by a gene editor facilitates the generation of knock-in animals, the HDR efficiency and the resulting rate of knock-in events are low [16] , in contrast to the high efficiency of Cas9 cleavage. Accordingly, the system needs to be optimized for practical use.

Various issues need to be resolved to achieve electroporationmediated knock-in of transgenes into zygotes/embryos. Owing to the greater sensitivity of in vitro-fertilized porcine zygotes to electricity compared with that of in vivo-derived mouse embryos [52, 56] , the size of molecules that can be introduced into zygotes/ embryos is limited. To efficiently deliver knock-in donor DNA into zygotes without mechanical injury, an adeno-associated viral (AAV) vector has been applied in mice [111] and rats [112] without removing the zona pellucida. Although AAV vector-mediated gene modification in porcine cells has been adapted to generate mutant pigs by combining it with SCNT techniques [113] , the investigation of gene modification during embryogenesis via an AAV vector is insufficient. The development of new and efficient techniques for delivering large molecules into zygotes and embryos is crucial.

A large number of disease-causing single-nucleotide polymorphisms have been identified in humans. Although post-DSB gene corrections by gene editors often induce random insertions and deletions at the target locus, the co-introduction of an ssODN as a template enables the introduction of point mutations in precise positions via the HDR pathway. In the use of gene editors, challenges related to the establishment of human disease models originating from point mutations [23, [114] [115] [116] and humanized pigs expressing human insulin [117] have been reported. However, the SCNT technique was used in almost all of these studies [114] [115] [116] [117] . Inhibition of NHEJ or enhancement of HDR is crucial for achieving targeted gene knock-ins or point mutations at precise positions during embryogenesis [118] . At present, the low frequency of HDRs in porcine zygotes/embryos limits the utilization of this methodology. Despite progress in trials aimed at enhancing HDR using an NHEJ inhibitor or HDR enhancer in cell lines and mouse/rabbit embryos [119] , studies using porcine zygotes/embryos are required.

The CRISPR/Cas-mediated base editor system, another approach for the introduction of a point mutation at a precise position without dependence on HDR, generates mutations at a single-base level [120, 121] . Cytosine base editors convert targeted C-G base pairs to T-A pairs, and adenine base editors convert targeted A-T pairs into G-C pairs without causing DSBs. Wang et al. demonstrated base editing in porcine fetal fibroblast cells using a modified base editor system [122] , and Xie et al. generated base-edited pigs via cytoplasmic microinjection and SCNT [123] . These studies further support the feasibility of using pigs as human disease models. Although there are some technical limitations, such as insufficient specificity, protospacer adjacent motif (PAM) compatibility concerns, and a narrow active window [124] , this technology has the potential to revolutionize gene therapy for genetic diseases and enable the efficient generation of animal models of diseases.

Owing to the development of gene-editing technologies, the generation of genetically modified pigs has dramatically expanded. However, some limitations remain. SCNT using gene-edited somatic cells ensures the generation of desired mutations in the resulting pigs, but requires sophisticated techniques. Microinjection-and electroporation-mediated gene editing are simple but limited by insecure knockout/knock-in efficiencies and mosaicism. However, various types of gene editors and their related technologies can be effectively applied to pigs using optimized and appropriate methods for introduction. In the future, gene editors will enable the on-demand preparation of pigs carrying desired mutations, including precise knock-ins.

The authors declare no conflicts of interest. 

Domestic animal models for biomedical research

Production of transgenic rabbits, sheep and pigs by microinjection

Production of transgenic miniature pigs by pronuclear microinjection

Development of efficient strategies for the production of genetically modified pigs

Derivation of porcine pluripotent stem cells for biomedical research

Cloned pigs produced by nuclear transfer from adult somatic cells

Pig cloning by microinjection of fetal fibroblast nuclei

Production of cloned pigs from in vitro systems

Somatic cell nuclear transfer cloning: practical applications and current legislation

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

An improved zinc-finger nuclease architecture for highly specific genome editing

Targeting DNA double-strand breaks with TAL effector nucleases

Multiplex genome engineering using CRISPR/Cas systems

RNA-guided human genome engineering via Cas9

Molecular mechanisms of DNA double strand break repair

Differential usage of nonhomologous end-joining and homologous recombination in double strand break repair

Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity

CRISPR/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects

Highfrequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

Origins of programmable nucleases for genome engineering

Frequency of off-targeting in genome edited pigs produced via direct injection of the CRISPR/Cas9 system into developing embryos

Efficient generation of gene-modified pigs harboring precise orthologous human mutation via CRISPR/Cas9-induced homology-directed repair in zygotes

Generation of PPARγ mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning

Efficient generation of myostatin mutations in pigs using the CRISPR/Cas9 system

Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting

No excessive mutations in transcription activator-like effector nuclease-mediated α-1,3-galactosyltransferase knockout Yucatan miniature pigs

Latest developed strategies to minimize the off-target effects in CRISPR-Cas-mediated genome editing

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

CRISPR FokI dead Cas9 system: principles and applications in genome engineering

Targeted insertion of an anti-CD2 monoclonal antibody transgene into the GGTA1 locus in pigs using FokI-dCas9

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Rationally engineered Cas9 nucleases with improved specificity

Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos

One-step generation of knockout pigs by zygote injection of CRISPR/Cas system

Production of human albumin in pigs through CRISPR/Cas9-mediated knockin of human cDNA into swine albumin locus in the zygotes

Gene targeting, genome editing: from Dolly to editors

Recent advances and future perspectives of in vivo targeted delivery of genome-editing reagents to germ cells, embryos, and fetuses in mice

Somatic cell reprogramming-free generation of genetically modified pigs

Generation of a TP53-modified porcine cancer model by CRISPR/ Cas9-mediated gene modification in porcine zygotes via electroporation

Generation of viable PDX1 gene-edited founder pigs as providers of nonmosaics

Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes

Effects of voltage strength during electroporation on the development and quality of in vitro-produced porcine embryos

Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases

Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs

Efficient TALEN-mediated gene knockout in livestock

Biallelic knockout of the α-1,3 galactosyltransferase gene in porcine liver-derived cells using zinc finger nucleases

Generation of GGTA1 biallelic knockout pigs via zinc-finger nucleases and somatic cell nuclear transfer

Highly efficient generation of GGTA1 biallelic knockout inbred mini-pigs with TALENs

Production of α1,3-galactosyltransferase targeted pigs using transcription activator-like effector nuclease-mediated genome editing technology

Efficient generation of GGTA1-null Diannan miniature pigs using TALENs combined with somatic cell nuclear transfer

Generation of GGTA1 mutant pigs by direct pronuclear microinjection of CRISPR/ Cas9 plasmid vectors

Efficient production of biallelic GGTA1 knockout pigs by cytoplasmic microinjection of CRISPR/Cas9 into zygotes

Generation of α1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs

Efficient production of multi-modified pigs for xenotransplantation by 'combineering', gene stacking and gene editing

Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning

Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH

Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2

Reduced human platelet uptake by pig livers deficient in the asialoglycoprotein receptor 1 protein

Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver

Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer

Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies

Porcine endogenous retrovirus (PERV) -molecular structure and replication strategy in the context of retroviral infection risk of human cells

Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses

Genome-wide inactivation of porcine endogenous retroviruses (PERVs)

Assessing the true incidence of mosaicism in preimplantation embryos

Mosaicism diminishes the value of pre-implantation embryo biopsies for detecting CRISPR/Cas9 induced mutations in sheep

An overview of currently available molecular Cas-tools for precise genome modification

Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity

Production of non-mosaic genome edited porcine embryos by injection of CRISPR/Cas9 into germinal vesicle oocytes

Efficient mutagenesis by CRISPR/Cas system during meiotic maturation of porcine oocytes

Genome mutation after introduction of the gene editing by electroporation of Cas9 protein (GEEP) system in matured oocytes and putative zygotes

Effects of concentration of CRISPR/Cas9 components on genetic mosaicism in cytoplasmic microinjected porcine embryos

Effects of electroporation treatment using different concentrations of Cas9 protein with gRNA targeting Myostatin (MSTN) genes on the development and gene editing of porcine zygotes

Onestep generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering

Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems

Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos

One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system

Evaluation of multiple gene targeting in porcine embryos by the CRISPR/Cas9 system using electroporation

One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs

CRISPR/Cas9-mediated integration of large transgene into pig CEP112 Locus

Generation of pRSAD2 gene knock-in pig via CRISPR/Cas9 technology

Establishment of gene-edited pigs expressing human blood-coagulation factor VII and albumin for bioartificial liver use

Preparation of a new type 2 diabetic miniature pig model via the CRISPR/Cas9 system

Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome

A Huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease

Production of gene-edited pigs harboring orthologous human mutations via double cutting by CRISPR/Cas9 with long single-stranded DNAs as homology-directed repair templates by zygote injection

Intra-embryo gene cassette knockin by CRISPR/Cas9-mediated genome editing with adeno-associated viral vector

Efficient derivation of knock-out and knock-in rats using embryos obtained by in vitro fertilization

Targeted genome editing by recombinant adeno-associated virus (rAAV) vectors for generating genetically modified pigs

Successful knock-in of hypertrophic cardiomyopathymutation R723G into the MYH7 gene mimics HCM pathology in pigs

CRISPR/Cas9-mediated generation of Guangxi Bama minipigs harboring three mutations in α-synuclein causing

Engineered pigs carrying a gain-of-function NLRP3 homozygous mutation can survive to adulthood and accurately recapitulate human systemic spontaneous inflammatory responses

Genetically humanized pigs exclusively expressing human insulin are generated through custom endonucleasemediated seamless engineering

Methodologies for improving HDR efficiency

Modulation of DNA double-strand break repair as a strategy to improve precise genome editing

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage

Cytosine base editor (hA3A-BE3-NG)-mediated multiple gene editing for pyramid breeding in pigs

Efficient base editing for multiple genes and loci in pigs using base editors

CRISPR/Cas-mediated base editing: technical considerations and practical applications

Efficient nonmeiotic allele introgression in livestock using custom endonucleases

Generation of RUNX3 knockout pigs using CRISPR/Cas9-mediated gene targeting

Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer

Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy

Generation of insulin-deficient piglets by disrupting INS gene using CRISPR/Cas9 system

Porcine zygote injection with Cas9/sgRNA results in DMD-modified pig with muscle dystrophy

CRISPR/Cas9-mediated ApoE-/-and LDLR-/-double gene knockout in pigs elevates serum LDL-C and TC levels

Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs

Creation of miniature pig model of human Waardenburg syndrome type 2A by ENU mutagenesis

CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs

SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype

Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts

Modeling lethal X-linked genetic disorders in pigs with ensured fertility

Efficient bi-allelic gene knockout and site-specific knock-in mediated by TALENs in pigs

Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer

A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing

PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model

Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA

Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs

Optimization strategy for generating gene-edited Tibet minipigs by synchronized oestrus and cytoplasmic microinjection

IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours

Efficient generation of B2m-null pigs via injection of zygote with

Generation of germline ablated male pigs by CRISPR/Cas9 editing of the NANOS2 gene

CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs

Editing porcine IGF2 regulatory element improved meat production in Chinese Bama pigs

Resistance to coronavirus infection in amino peptidase N-deficient pigs

Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression